Altheda Wellness Innovation is a Canadian natural product innovation company. Altheda develops scientifically backed and pharmacist developed dietary supplements for aging well, under the brand Yew Healthy Aging Nutraceuticals. With tailored, evidence-based solutions for bladder, ocular, brain, and metabolic health, Altheda's living well approach is helping to narrow the gap between healthspan and lifespan.

Koast Analytics is a health technology company transforming the way movement is measured and used in healthcare. Built on decades of research in orthopaedic biomechanics and human movement analysis, Koast combines computer vision and advanced analytics to deliver rapid, objective, and clinically meaningful assessment of human movement that integrates seamlessly into routine clinical workflows. Koast enables objective assessment of patient function at scale to support orthopaedic clinical triage, patient prioritization, treatment planning, and outcome assessment, helping improve both healthcare efficiency and patient outcomes.

HemoLyf™ is a Canadian biotechnology venture developing next-generation hemostatic materials for rapid and reliable bleeding control. Our patent-pending biomaterial technology is designed to accelerate clot formation, reduce blood loss, and remain effective even in challenging conditions, including patients with impaired coagulation or those taking blood-thinning medications.

Originating from research at Dalhousie University, HemoLyf™is advancing its technology for use in emergency medicine, periodontal and oral surgery, trauma care, and other clinical applications where fast and dependable blood clotting can improve patient outcomes and reduce the burden on healthcare systems.

Tartan Rehab was established in 1990 in Halifax, Nova Scotia, Canada to enhance the participation of people who use wheeled mobility devices, without compromising safety.

Oncolinc Therapeutics was founded to address a fundamental challenge in oncology: overcoming tumor-driven immune suppression. We are developing first-in-class therapeutics with the potential to unlock new treatment strategies and extend the benefits of immunotherapies.

The Integrated Microbiome Resource (IMR) provides sequencing and bioinformatics solutions for microbiome research across academic, government, and commercial sectors. The IMR has established an international client base spanning more than 50 countries and has processed over 400,000 samples, delivering services that span microbial community profiling, metagenomics, bioinformatics, and data interpretation. As a growing microbiome solutions company, IMR is focused on advancing new technologies, strategic partnerships, and innovative analytical platforms.